BPTH - Bio-Path Holdings, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
-
0
37
13
Cost of Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Expenses
Research Development
3,798
4,603
5,480
5,474
Selling General and Administrative
3,784
3,379
3,523
3,014
Total Operating Expenses
7,582
7,982
9,003
8,488
Operating Income or Loss
-7,582
-7,982
-8,966
-8,475
Interest Expense
-
-
-
-
Total Other Income/Expenses Net
-
-608
1,934
1,713
Income Before Tax
-8,119
-8,583
-7,023
-6,750
Income Tax Expense
-
-
-
-
Income from Continuing Operations
-8,119
-8,583
-7,023
-6,750
Net Income
-8,119
-8,583
-7,023
-6,750
Net Income available to common shareholders
-8,119
-8,583
-8,061
-6,750
Reported EPS
Basic
-
-14.38
-16.00
-14.00
Diluted
-
-14.38
-16.00
-14.00
Weighted average shares outstanding
Basic
-
597
504
464
Diluted
-
597
504
464
EBITDA
-
-7,556
-8,555
-8,271